Chinese medicine has a long history of handling cancer, in recent years particularly, has produced satisfying results in such fields as attenuation and synergia for chemo, post-operation convalescence, reducing recurrence or metastasis, and improving survival time also quality of life. Nevertheless standardized therapeutic regimen is necessary for further promotion. It is a system engineering that starts with therapeutic principle and method and based on optimal clinical evidences. A systematic, self-contained, standardized therapeutic regimen shall be the result of verification and optimization by rigid randomized clinical trial and system evaluation under guidance of evidence-based medicine. However, there is lack of convincing data and results due to individualized therapy and scatter clinical data. Suitable standardized therapeutic regimen or guideline results from multi-centered randomized clinical evidences. Fortunately researchers of Chinese medicine are aware of the problem and gradually take measures in this aspect. With further development of theory and technology, and increasing clinical evidence, we will hopefully welcome the advent of a evidence-based standardized therapeutic regimen, ushering in a new era of Chinese oncology.